PTEN and non-small cell lung carcinoma: Therefore, we further found that miR-25-3p negatively regulates the expression of PTEN, and activates the PI3K/AKT signaling pathway, which might be considered as a latent mechanism for promoting cisplatin resistance in NSCLC.